Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry

Spremljeno u:
Bibliografski detalji
Izdano u:Inflamm Bowel Dis
Glavni autori: Agrawal, Manasi, Brenner, Erica J, Zhang, Xian, Modesto, Irene, Woolcott, John, Ungaro, Ryan C, Colombel, Jean-Frederic, Kappelman, Michael D
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Clinical Brief Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7799122/
https://ncbi.nlm.nih.gov/pubmed/33325523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izaa303
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items